Quintin J. Lai - 14 Mar 2022 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
VP Corp Development & Strategy
Signature
Ryan Metz as Agent for Quintin J. Lai
Issuer symbol
WST
Transactions as of
14 Mar 2022
Net transactions value
-$2,284,044
Form type
4
Filing time
16 Mar 2022, 11:16:19 UTC
Previous filing
24 Feb 2022
Next filing
23 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $230,019 +2,440 +45% $94.27* 7,812 14 Mar 2022 Direct
transaction WST Common Stock Options Exercise $465,429 +5,576 +71% $83.47* 13,388 14 Mar 2022 Direct
transaction WST Common Stock Sale $466,604 -1,271 -9.5% $367.12 12,117 14 Mar 2022 Direct F1
transaction WST Common Stock Sale $149,017 -405 -3.3% $367.94 11,712 14 Mar 2022 Direct F2
transaction WST Common Stock Sale $463,801 -1,254 -11% $369.86 10,458 14 Mar 2022 Direct F3
transaction WST Common Stock Sale $165,441 -446 -4.3% $370.94 10,012 14 Mar 2022 Direct F4
transaction WST Common Stock Sale $223,132 -600 -6% $371.89 9,412 14 Mar 2022 Direct F5
transaction WST Common Stock Sale $335,632 -900 -9.6% $372.92 8,512 14 Mar 2022 Direct F6
transaction WST Common Stock Sale $1,100,881 -2,940 -35% $374.45 5,572 14 Mar 2022 Direct F7
transaction WST Common Stock Sale $74,984 -200 -3.6% $374.92 5,372 14 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Options (Right to buy) Options Exercise $0 -2,440 -6.6% $0.000000 34,640 14 Mar 2022 Common Stock 2,440 $94.27 Direct
transaction WST Stock Options (Right to buy) Options Exercise $0 -5,576 -16% $0.000000 29,064 14 Mar 2022 Common Stock 5,576 $83.47 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $366.50 to $367.42, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F2 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $367.56 to $368.22, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F3 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $369.40 to $370.36, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F4 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $370.41 to $371.32, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F5 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $371.65 to $372.40, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F6 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $372.70 to $373.46, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F7 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $373.86 to $374.83, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.